Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rhinoconjunctivitis”

243 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 243 results

Large-scale testing (Phase 3)Study completedNCT00263601
What this trial is testing

Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis

Who this might be right for
Grass Pollen Allergy
Allergopharma GmbH & Co. KG 154
Testing effectiveness (Phase 2)Study completedNCT01438463
What this trial is testing

PURETHAL® Mites Dose Range Finding Study in Patients With Persistent Allergic Rhinitis/Rhinoconjunctivitis

Who this might be right for
Allergic RhinitisAllergic Rhinoconjunctivitis
HAL Allergy 290
Large-scale testing (Phase 3)Ended earlyNCT04874714
What this trial is testing

Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis

Who this might be right for
Allergic RhinoconjunctivitisPerennial Allergic RhinitisHouse Dust Mite Allergy+1 more
Inmunotek S.L. 18
Testing effectiveness (Phase 2)Study completedNCT01567306
What this trial is testing

Phase II Trial With Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense

Who this might be right for
Allergic Rhinoconjunctivitis
Roxall Medicina España S.A 151
Testing effectiveness (Phase 2)Study completedNCT00574704
What this trial is testing

Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

Who this might be right for
Perennial Allergic RhinoconjunctivitisHouse Dust Mite Allergy
Cytos Biotechnology AG 40
Not applicableStudy completedNCT01923792
What this trial is testing

ToleroMune House Dust Mite Follow on Study

Who this might be right for
House Dust Mite AllergyRhinoconjunctivitis
Circassia Limited 105
Testing effectiveness (Phase 2)Study completedNCT00666341
What this trial is testing

Dose-Response-Study With a Recombinant Cocktail of Phleum (rPhleum) Allergens

Who this might be right for
Type I-Allergy
Allergopharma GmbH & Co. KG 50
Large-scale testing (Phase 3)Study completedNCT00421655
What this trial is testing

A Trial of Grazax in Subjects With Hayfever

Who this might be right for
Allergy
ALK-Abelló A/S 329
Early research (Phase 1)Study completedNCT02849210
What this trial is testing

A Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Rhinoconjuncitivis Sensitized to Olea Europaea

Who this might be right for
Rhinoconjunctivitis
Roxall Medicina España S.A 47
Testing effectiveness (Phase 2)Study completedNCT01385800
What this trial is testing

ToleroMune Grass Exposure Unit Study

Who this might be right for
Grass AllergyRhinoconjunctivitis
Circassia Limited 280
Large-scale testing (Phase 3)Study completedNCT00916760
What this trial is testing

Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Parietaria Judaica

Who this might be right for
Allergic Rhinoconjunctivitis
Laboratorios Leti, S.L. 153
Early research (Phase 1)Study completedNCT00310453
What this trial is testing

Tolerability of ALK Grass Tablet in Children

Who this might be right for
Allergy
ALK-Abelló A/S 32
Early research (Phase 1)Study completedNCT01383590
What this trial is testing

Identification of Potential Biomarkers of Peptide Immunotherapy. Part 1 - Proteomics Analysis

Who this might be right for
Cat Allergy
Circassia Limited 10
Large-scale testing (Phase 3)Study completedNCT00824447
What this trial is testing

Long-term Efficacy and Safety Study With Oralgen Grass Pollen

Who this might be right for
Allergic Rhinoconjunctivitis
Artu Biologicals 356
Testing effectiveness (Phase 2)Study completedNCT02166268
What this trial is testing

Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an Environmental Challenge Chamber

Who this might be right for
Grass Pollen Induced Allergic Rhinoconjunctivitis
ALK-Abelló A/S 140
Testing effectiveness (Phase 2)Study completedNCT00777374
What this trial is testing

Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects With Epicutanoeus Allergen Administration

Who this might be right for
Allergic Rhinoconjunctivitis
University of Zurich 97
Testing effectiveness (Phase 2)Study completedNCT01682070
What this trial is testing

SUBLIVAC FIX Phleum Pratense DT/DRF

Who this might be right for
Allergic RhinitisAllergic Rhinoconjunctivitis
HAL Allergy 266
Large-scale testing (Phase 3)Study completedNCT00264459
What this trial is testing

Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture

Who this might be right for
Grass Pollen Allergy
Allergopharma GmbH & Co. KG 160
Post-approval studies (Phase 4)Study completedNCT02437786
What this trial is testing

Molecular and Cellular Mechanism in Rhinitis Allergic Patients Treated With GRAZAX®

Who this might be right for
Allergic Rhinoconjunctivitis
ALK-Abelló A/S 58
Not applicableStudy completedNCT01949415
What this trial is testing

An Optional Investigation of Biomarkers of Efficacy

Who this might be right for
Rhinoconjunctivitis
Circassia Limited 105
Load More Results